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Background/aim: Currently, there is not any specific treatment for chronic pancreatitis (CP). It was aimed to investigate the effects of
melatonin administration on endoplasmic reticulum (ER) stress, oxidative stress, fibrosis, biochemical and histopathological parameters,
and Abcc2,Abcc5, and Abcg2 gene levels in an experimental rat CP model.
Materials and methods: Forty rats were randomized into five groups: Sham, CP, CP+25 mg/kg melatonin, CP+50 mg/kg melatonin,
and CP+placebo. In all rats, except the sham group, a model of chronic pancreatitis was accomplished with intraperitoneal caerulein
administration. In treatment groups, melatonin was used as a therapeutic agent. Serum TGF-β, TNF-α, MDA and GPx levels were
studied. Pancreatic tissues were evaluated histopathologically. The expression levels of αSma,IR1α,Perk,Abcc2,Abcc5, and Abcg2 genes
were measured with the qRT-PCR.
Results: Biochemical results of the melatonin groups exhibited favorable changes compared to the CP and placebo groups. αSma,IR1α,Perk
expression levels were significantly lower in the melatonin groups. The expression levels of Abcc2, Abcc5, and Abcg2 were significantly
higher in the CP group compared to the sham group, and these gene levels were significantly lower in the melatonin groups compared
to the CP group (p < 0.01, p < 0.05, p < 0.05, respectively).
Conclusion: In light of these favorable positive results, melatonin may be a useful preventive agent in the course of CP.
Key words: Chronic pancreatitis, rat, melatonin, endoplasmic reticulum, ABC transporter genes

1. Introduction
Chronic pancreatitis (CP) is a disease characterized
by progressive damage to the exocrine and endocrine
parenchyma of the pancreas and is usually induced by
alcohol and tobacco use [1]. Genetic and environmental
factors also cause CP. It reduces the patient quality of
life, causes other systemic diseases and can also lead to
pancreatic cancer [2-4].
As with many chronic diseases, the mechanism of
chronic pancreatitis is complex. Oxidative stress, impaired
autophagy, ER stress, activation of proinflammatory
cytokines, and increased apoptosis/necrosis have all been
outlined in the pathogenesis of chronic pancreatitis. CP
therapy mainly involves symptomatic treatments such
as pain relief and replacement therapy for exocrine and

endocrine insufficiency. Currently, there is no globally
accepted effective treatment method for the clinical
picture of CP [2–4]. For this reason, there is a great need
to find new agents to prevent and treat CP as a first step
and to determine the molecular structure of this disease.
Melatonin is a hormone secreted from the pineal gland, with
antioxidant and powerful antiinflammatory properties.
Melatonin, which is associated with strengthening
immune defense and modulation of apoptosis, has various
functions within the cell, such as protecting the organism
from damage caused by toxic radicals [5].
Melatonin protects tissues directly by the destruction
of reactive oxygen and nitrogen species or indirectly
by supporting the expression of antioxidant enzymes
such as catalase (CAT), superoxide dismutase (SOD),
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glutathione peroxidase (GPx), and glutathione reductase
(GR) [6, 7]. In addition, melatonin reduces the production
of proinflammatory cytokines such as interleukin 1β,
interleukin 6 (IL-6), interleukin 22, and tumor necrosis
factor α (TNFα) [8].
The ABC gene family are transmembrane proteins
that are expressed in lung, heart, pancreas, liver, kidneys,
blood-brain barrier and placenta [9]. They have important
roles in the transport of drugs, antibiotics, and toxins
across biological membranes [10]. ABC transporters
strongly affect drug absorption and pharmacokinetics.
The effect of multidrug resistant proteins (ABC multidrug
resistance) in many diseases is not widely known. There
is no study in the literature about the expression and
importance of the ABC proteins Abcg2, Abcc2, and Abcc5
in the pancreas in an experimental CP model. There are
articles showing the positive effects of melatonin in an
experimental acute pancreatitis model, but the effects of
melatonin in the experimental CP model was examined
for the first time in this current study. In this study, the aim
was to investigate the effects of melatonin administration
on endoplasmic reticulum (ER) stress, oxidative stress,
fibrosis, biochemical, and histopathological parameters
and Abcc2, Abcc5, and Abcg2 gene expression levels in an
experimental rat chronic pancreatitis (CP) model.
2. Materials and methods
2.1. Rat groups
This research was conducted with the approval of
the University of Health Sciences, Hamidiye Animal
Experiments Local Ethics Committee, Turkey and the
study was carried out in the University of Health Sciences
Animal Experiments Center. Forty adult 16-20-week-old
male Sprague Dawley rats weighing 250–350 g were used.
Rats were housed in cages at approximately 24 °C. Food
intake of animals, was stopped 12 h before sacrifice. Rats
were randomized into five equal groups:
Group 1: Sham group (1 cc of saline was injected
intraperitoneally (ip) twice a day at 09:00 a.m. and 10:00
a.m for 6 weeks, 3 days per week (Monday, Wednesday,
Friday), and no other medication was administered).
Group 2: CP group (50 mcg/kg caerulein was injected
ip twice a day (at 09:00 a.m. and 10:00 a.m) for 6 weeks, 3
days per a week.
Group 3: CP+melatonin 25 mg/kg group (caerulein
injections were performed as Group 2, melatonin was
administered at a dose of 25 mg/kg ip, 3 days per a week
for 6 weeks, 1 h before the caerulein injections, beginning
from the first week of the study).
Group 4: CP+melatonin 50 mg/kg group (caerulein
injections were performed as Group 2, melatonin was
administered at a dose of 50 mg/kg ip, 3 days per a week
for 6 weeks, 1 h before the caerulein injections, beginning
from the first week of the study).

Group 5: Placebo group (caerulein injections were
performed as Group 2, saline was injected IP at a dose of 1
cc ip, 3 days per a week for 6 weeks, 1 h before the caerulein
injections, beginning from the first week of the study).
All rats were sacrificed 24 h after the last injections.
Under general anesthesia, the rats were sacrificed by
taking blood samples from the right atrium. The study
was terminated after the pancreatic tissue samples were
obtained. All blood samples were centrifuged at 5000 rpm
for 10 min and then stored at –80 °C until biochemical
analysis.
2.2. Biochemical analysis
TGF-β, TNF-α, GPx, MDA: Levels of TGF-β
(transforming growth factor-beta), TNF-α, GPx and MDA
(malondialdehyde) were tested with ELISA kits [Bioassay
Technology Laboratory (BT Lab). Antibodies specific to
rat TGF-β were placed in cavities within the Microtiter
strips, followed by the addition of a second biotinylated
antibody inside the wells. Serum samples were placed
inside the wells using a pipette. All tests were carried out
according to the instructor’s protocol.
2.3. Histopathological evaluation
Histopathological evaluation was made to evaluate
pancreatic damage. After the rats were sacrificed, the
pancreatic tissue was fixed in 10% buffered formaldehyde
and then embedded in paraffin. Then, 3 μm thick sections
were made from the paraffin blocks and hematoxylin &
eosin staining was performed. Evaluation of pancreatic
damage was performed by a blind pathologist. All samples
were examined for inflammation, atrophy, and fibrosis.
Correspondence analysis was performed to determine
which histopathological scores were more common in
which group.
2.4. Molecular methods
RNA isolation from pancreatic tissue samples: RNA
isolation was performed from paraffinized pancreas
tissues of rats with MasterPure Complete DNA and
RNA purification kit (Lucigen, USA) according to the
manufacturer’s protocol. RNA concentration and purities
were measured with the aid of a Denovix DS-11 (DeNovix
Inc., Wilmington, DE) spectrophotometer.
cDNA synthesis and real time PCR (qRT-PCR):
Expression levels of Abcc2, Abcc5, and Abcg2 genes and
expression levels of a-SMA (in order to evaluate fibrosis
development), Ire1a and Perk (in order to evaluate
endoplasmic reticulum stress) genes were measured in all
RNA samples obtained from rat pancreatic tissues. CDNA
synthesis was completed using 500 ng of RNA. The cDNA
synthesis was performed according to the manufacturer’s
protocol using the Roche Transcriptor High Fidelity cDNA
Synthesis Kit, Roche (Switzerland). Gapdh was used as an
internal control. The samples were studied in duplicate
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with SYBR Green Master Mix from Roche (Switzerland)
on the LightCycler 480 instrument. SYBR Green qRT-PCR
was performed at 1 cycle of 95 °C for 5 min followed by 40
cycles of 95 °C for 10 s and 60 °C for 1 mins. Melting curve
analysis was performed at temperatures between 65 ℃ and
95 ℃. Primer sequences used for qRT-PCR are given in
Table 1.
Statistical analysis: IBM SPSS Statistics 20 software and
InStat3 GraphPad Statistics Software (trial version) were
used for all statistical analyses. P < 0.05 was considered
statistically significant. The significance between group
means ± standard deviation (SD) was analyzed by Tukey’s
test following one-way ANOVA. Relative quantitation
analysis of the results of real-time PCR experiments
was performed using the delta-delta-CT method. The
chi-square test was used to determine the variation in
histopathologic scores according to group.
3. Results
3.1. Biochemical results
When the study groups are examined in terms of TNF-α
levels, there were significant differences between the
CP group, placebo group and the low-dose and highdose treatment groups (p < 0.01). When rat groups were
examined in terms of TGF-β levels, again, there were
significant differences between the CP group, placebo

group and the low-dose and high-dose treatment groups
(p < 0.01). There was a significant difference in MDA
levels between the CP group and treatment groups (p <
0.001). Finally, there was a significant difference in GPx
levels between the CP group and treatment groups (p <
0.001). In other words, melatonin treatment significantly
improved oxidative stress in our experimental rat CP
model (Table 2).
3.2. Histopathological examination results
The histopathological scores were lower in the melatonin
treatment groups than in the CP and placebo groups.
The histopathological views of the experimental chronic
pancreatitis model are shown in Figure 1. (1a-Sham group,
1b-chronic pancreatitis group, 1c-low dose melatonin
group, 1d-high dose melatonin group)
There was no significant difference in histopathological
score between the low-dose melatonin group and the CP
and placebo groups (p > 0.05). There was a significant
difference between the high-dose melatonin group and
the CP and placebo groups (p < 0.05). Distribution of
histopathologic scores by groups were given in Table 3.
3.3. Molecular results
The expression values of a-Sma (for fibrosis), Ire1a and
Perk (for endoplasmic reticulum stress), and Abcc2,
Abcc5, and Abcg2 genes were determined by qRT-PCR in
the pancreatic tissues of rats. The expression levels of all

Table 1. Primer list of all genes which were evaluated in this current study.
Gene Name

Forward

Reverse

Abcc2

CTGGTTGGAAACTTGGTCG

CAACTGCCACAATGTTGGT

Abcc5

AACAGGAAGGATTCTCAACAGG

TGAATGCTGGACGTGATATGG

Abcg2

AGTCCGGAAAACAGCTGAGA

CCCATCACAACGTCATCTTG

Ire1α

CCTGAGGAATTACTGGCTTCTC

TCCAGCATCTTGGTGGATG

Perk

CGCTGCTGCTGCTGTTCCTG

GCAATGCCTCGGCGTCTTCC

α-sma

TTCCAGCCTTCCTTTATCG

TTGGCGTACAGGTCCTTC

Gapdh

TATCGGACGCCTGGTTAC

CTGTGCCGTTGAACTTGC

Table 2. Mean results and p values of biochemical parameters.
Group 1 (CP)

Group 2(LD)

Group 3(HD)

Group 4(P)

Group 5(S)

p

GPx (ng/ml)

9.9 ± 3.7

13.01 ± 4.1

16.20 ± 3.9

9.66 ± 4.6

20.2 ± 5.2

p < 0.01*

TNF-alpha (ng/ml)

68.76 ± 9.2

50.35 ± 5.1

42.25 ± 6.6

61.13 ± 5.8

35.97 ± 7.4

p < 0.01*

MDA (nmol/ml)

2.39 ± 0.3

1.32 ± 0.2

1.01 ± 0.1

2.33 ± 0.4

0.8 ± 0.2

p < 0.001**

TGF-β (ng/L)

266.23 ± 15.9

194.7 ± 14.6

168.96 ± 16.6

259.8 ± 13.2

150.28 ± 9.1

p < 0.01*

One Way ANOVA test was used. Data is given as mean ± SD. CP: Chronic pancreatitis group, LD: Low dose melatonin group, HD: High
dose melatonin group, P :Placebo group, S: Sham group, GPx:Glutathione peroxidase, TNF-alpha: Tumor necrosis factor-alpha, MDA:
Malondialdehyde, TGF-β:Transforming growth factor *p < 0.01, **p < 0.001.
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Figure 1. Hematoxylin and eosin (H&E) staining of pacreatic tissue samples. (a) Sham group, (pancreatic tissue with normal
configuration and acinar structure) HE ×100, (b) chronic pancreatitis group, (dense inflammation, edema and glandular atrophy in
pancreatic acinar structures with adjacent fibrosis) HE ×200, (c) low dose melatonin group (mild inflammation and minimal fibrosis in
periductal area) HE ×100, (d) high dose melatonin group (minimal to mild inflammation in pancreatic tissue) HE ×200.

genes exhibited significant changes between the CP and
sham groups (Ire1a p=0.03, Perk p=0.01, a-Sma p=0.01,
Abcc2 p = 0.006, Abcc5 p = 0.04 and Abcg2 p = 0.01). The
expression levels of Ire1a, Perk, a-Sma were lower in the
high-dose melatonin group compared to the CP group
(p < 0.01, p < 0.05, p < 0.05, respectively) (Figure 2a, 2b,
2c). The expression levels of Abcc2, Abcc5 and Abcg2 genes
were higher in the CP group compared to sham groups (p <
0.01, p < 0.05, p < 0.05, respectively). When the expression
levels of Abcc2, Abcc5 and Abcg2 genes were compared,
Abcc2 and Abcg2 genes had lower expression levels in the
high-dose group compared to the low-dose group (for all
genes, p < 0.05) (Figures 2d–2f). For Abcc5, there was no
significant difference in the expression levels of the highdose melatonin and CP groups (Figure 2e). When the lowdose melatonin and CP groups were examined in terms

of Abcg2 gene expression levels, we found no significant
difference (p > 0.05) (Figure 2f). Abcc2 expression level
was significantly down regulated for low- and high-dose
melatonin group compared to CP groups (p < 0.05)
(Figure 2d).
4. Discussion
Chronic pancreatitis is an inflammatory process in the
exocrine and endocrine glandular pancreatic parenchyma
resulting in progressive and irreversible damage and
fibrosis. Currently, there is no single therapeutic agent
for the etiopathogenesis of chronic pancreatitis, a disease
with high morbidity rates [11]. This current research is
the first study in the literature that examines the efficacy
of melatonin in preventing the development of chronic
pancreatitis and the effect of drug resistance genes at the
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Table 3. Distribution of histopathological scores by groups.
Histopathological Scores

Groups

Total

Total

None

Mild

Moderate

Severe

Low-dose

0

3

4

1

8

CP

0

1

3

4

8

Placebo

0

1

4

3

8

Sham

8

0

0

0

8

High-dose

1

4

3

0

8

9

9

14

8

40

Note: A correspondence analysis was applied to determine which histopathological scores
appeared more in which group. The difference between the high-dose group and CP and
placebo group was significant (p < 0.05).

Figure 2. Expression levels of (a)IRE1a, (b)Perk, (c)a-Sma, (d)Abcc2, (e)Abcc5, and (f) Abcg2 in CP compared with the treatment
groups and control. Data are expressed as the relative fold change among data sets, and each was performed in triplicate. CP:
chronic pancreatitis, S: sham, HD: high dose melatonin, LD: low dose melatonin. One-way ANOVA with Tukey’s post-hoc test
was used *p < 0.05, **p < 0.01.

histopathological, biochemical, and molecular levels in an
experimental chronic pancreatitis model.
There are many methods that enable the induction of
an experimental chronic pancreatitis model. One of these
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common applications is the model created with repeated
caerulein injections [4, 12]. In previous studies, caerulein
was shown to trigger cell necrosis by inhibition of the Wnt
/ β-Catenin pathway and lead to increased inflammatory
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cytokines. In-vivo studies showed that caerulein injection
causes edema, inflammation, and necrosis in pancreatic
acinar cells [13, 14].
Although recent studies provide us with a better
understanding of the progression of chronic pancreatitis,
there are still unclear points in the physiopathology.
However, considering the multifactorial disease and
complex clinical picture, the treatment of patients with
CP is difficult and the applied methods result in failure in
terms of treatment. In the literature, it was reported that the
inhibitory effect of melatonin on the immune response is
related to the antioxidant property of the molecule and that
neutrophil activation prevents oxidant damage in tissues
[15]. The absence of melatonin toxicity also supports
that this agent can be used safely in many inflammatory
processes like CP.
Although the efficacy of melatonin in the experimental
CP model was not investigated in the literature, it was
shown to have beneficial effects in many experimental
acute pancreatitis models, and it is effective in reducing
pancreatic damage and oxidative stress. Additionally, it was
reported to reduce the severity of acute pancreatitis [16].
Melatonin was reported to regulate insulin secretion and
has a protective effect on endoplasmic reticulum stress in
an experimental acute pancreatitis model [17]. Melatonin
protects against acute pancreatitis-associated pancreatic
injury by down-regulation of IRE1α-mediated JNK/NF-κB
pathways in rats [18]. Previously, Yildirim et al. performed
an experimental rat CP study and used pentoxifylline as
a therapeutic agent [13]. They showed that pentoxifylline
decreased the inflammatory response and oxidative stress.
In other words, their therapeutic agent had preventive
efficacy in an experimental CP model. Similarly, in this

current experimental CP model, we showed that melatonin
ameliorated inflammatory response, oxidative stress, and
endoplasmic reticulum stress.
The varying expression levels of ABC transporter
genes are responsible for drug resistance in many chronic
diseases and cancer [19]. Up-regulation of many kind of
ABC transporters, including ABCB1 and ABCG2 leads to
diminished cellular drug efflux [20]. Compatible with this
fact, in this current study, we found significantly changed
expression levels of ABC genes in the CP group. For the first
time in the literature, in this current study, the expression
levels of Abcg2, Abcc5, and Abcg2 genes were investigated in
an experimental CP model in which melatonin was used as
a therapeutic agent.
In this current study, it has been shown that
melatonin has positive protective properties, ameliorates
inflammation, oxidative stress and pancreatic fibrosis.
Moreover, it affects Ire1a, Perk, a-Sma, Abcc2, Abcc5, and
Abcg2 gene expression levels in an experimental CP model.
In other words, melatonin may be used as a preventive and
therapeutic option for CP in the future.
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